Encainide
Clinical data | |
---|---|
Trade names | Enkaid |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a605040 |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C22H28N2O2 |
Molar mass | 352.47 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Encainide |
Articles |
---|
Most recent articles on Encainide |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Encainide at Clinical Trials.gov Clinical Trials on Encainide at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Encainide
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Encainide Discussion groups on Encainide Directions to Hospitals Treating Encainide Risk calculators and risk factors for Encainide
|
Healthcare Provider Resources |
Causes & Risk Factors for Encainide |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Encainide (trade name Enkaid) is a class Ic antiarrhythmic agent. It is no longer used because of its frequent proarrhythmic side effects.[1]
References
- ↑ PMID 1900101 (PMID 1900101)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand